Search results for "Highlights"
Rivaroxaban associated with increased risk for GI bleeding compared to other DOACs
A study in Iceland of direct oral anticoagulants (DOACs) found a higher risk for overall and major GI bleeding with rivaroxaban than with either apixaban or dabigatran.
https://gastroenterology.acponline.org/archives/2021/10/22/1.htm
22 Oct 2021
Patients with mild acute diverticulitis can be safely treated without antibiotics in outpatient setting
Patients who presented to an ED and were randomized to receive only anti-inflammatory and symptomatic treatment had similar rates of hospitalization, return to the ED, and pain control as those who received the usual antibiotic treatment, a Spanish trial found.
https://gastroenterology.acponline.org/archives/2021/11/19/2.htm
19 Nov 2021
AGA releases new guidance on coagulation disorders in patients with cirrhosis
A clinical practice guideline from the American Gastroenterological Association (AGA) suggested against extensive preprocedural testing in patients with stable cirrhosis who are undergoing routine GI procedures, among other recommendations.
https://gastroenterology.acponline.org/archives/2021/11/19/3.htm
19 Nov 2021
Guideline from CRC task force recommends starting screening at ages 45 to 49 years in all average-risk patients
Increasing disease incidence and a favorable harm-benefit ratio are two reasons to expand the age range for colorectal cancer (CRC) screening to younger patients, a task force determined.
https://gastroenterology.acponline.org/archives/2021/11/19/1.htm
19 Nov 2021
Review finds upadacitinib most effective for moderate to severe ulcerative colitis remission
The systematic review and meta-analysis of biologic and small-molecule drugs for patients with moderate to severe ulcerative colitis also found that upadacitinib ranked highest for adverse events, whereas vedolizumab had the lowest rate of adverse events and serious adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/2.htm
17 Dec 2021
Bentonite hemostatic powder noninferior to standard care for GI bleeding
In a single-blind randomized controlled trial, bleeding was controlled within 30 days in 90.1% of adults with acute nonvariceal bleeding on upper GI endoscopy assigned to receive TC-325 versus 81.4% of those assigned to standard treatment.
https://gastroenterology.acponline.org/archives/2021/12/17/3.htm
17 Dec 2021
ACG guideline updates recommendations on diagnosis, management of GERD
Proton-pump inhibitors remain a standard treatment for gastroesophageal reflux disease (GERD) despite increased scrutiny of side effects, although new treatments are emerging, the guideline from the American College of Gastroenterology (ACG) stated.
https://gastroenterology.acponline.org/archives/2021/12/17/1.htm
17 Dec 2021
Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis
The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022
H. pylori eradication therapy may lead to better outcomes for functional dyspepsia
A systematic review and meta-analysis found that Helicobacter pylori eradication therapy was associated with higher cure rates and rates of symptom improvement in H. pylori-positive patients with functional dyspepsia.
https://gastroenterology.acponline.org/archives/2022/01/28/2.htm
28 Jan 2022
Q&A: A deeper dive into ACP's new diverticulitis guidelines
Authors discussed the College's first clinical guidelines on diagnosis and management of diverticulitis, which provide recommendations on when to use imaging, antibiotics, colonoscopy, and other interventions.
https://gastroenterology.acponline.org/archives/2022/01/28/1.htm
28 Jan 2022